ロピナビル・リトナビル
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Hung IF, et al.〔Lancet. 2020 May 30;395(10238):1695-1704〕(査読済み)